vs
Side-by-side financial comparison of Climb Global Solutions, Inc. (CLMB) and CareTrust REIT, Inc. (CTRE). Click either name above to swap in a different company.
Climb Global Solutions, Inc. is the larger business by last-quarter revenue ($182.4M vs $134.9M, roughly 1.4× CareTrust REIT, Inc.). CareTrust REIT, Inc. runs the higher net margin — 82.5% vs 1.8%, a 80.7% gap on every dollar of revenue. On growth, CareTrust REIT, Inc. posted the faster year-over-year revenue change (55.1% vs 32.1%). Over the past eight quarters, CareTrust REIT, Inc.'s revenue compounded faster (46.2% CAGR vs 40.7%).
Univar Solutions Inc. is a global chemical and ingredients distributor and provider of value-added services.
CareTrust REIT, Inc.CTREEarnings & Financial Report
Target Healthcare REIT is a British property investment company which invests in healthcare properties and holds a large portfolio of care homes. It is structured as a real estate investment trust (REIT) and is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index.
CLMB vs CTRE — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $182.4M | $134.9M |
| Net Profit | $3.3M | $111.3M |
| Gross Margin | 14.5% | — |
| Operating Margin | 2.1% | — |
| Net Margin | 1.8% | 82.5% |
| Revenue YoY | 32.1% | 55.1% |
| Net Profit YoY | -9.5% | 113.5% |
| EPS (diluted) | $0.18 | $0.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $182.4M | — | ||
| Q4 25 | $193.8M | $134.9M | ||
| Q3 25 | $161.3M | $132.4M | ||
| Q2 25 | $159.3M | $112.5M | ||
| Q1 25 | $138.0M | $96.6M | ||
| Q4 24 | $161.8M | $86.9M | ||
| Q3 24 | $119.3M | $77.4M | ||
| Q2 24 | $92.1M | $68.9M |
| Q1 26 | $3.3M | — | ||
| Q4 25 | $7.0M | $111.3M | ||
| Q3 25 | $4.7M | $74.9M | ||
| Q2 25 | $6.0M | $68.5M | ||
| Q1 25 | $3.7M | $65.8M | ||
| Q4 24 | $7.0M | $52.1M | ||
| Q3 24 | $5.5M | $33.4M | ||
| Q2 24 | $3.4M | $10.8M |
| Q1 26 | 14.5% | — | ||
| Q4 25 | 15.4% | — | ||
| Q3 25 | 15.9% | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 16.9% | — | ||
| Q4 24 | 19.3% | — | ||
| Q3 24 | 20.3% | — | ||
| Q2 24 | 20.2% | — |
| Q1 26 | 2.1% | — | ||
| Q4 25 | 4.9% | — | ||
| Q3 25 | 4.3% | 58.1% | ||
| Q2 25 | 5.0% | 61.3% | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | 7.2% | — | ||
| Q3 24 | 7.1% | 43.0% | ||
| Q2 24 | 4.6% | 15.1% |
| Q1 26 | 1.8% | — | ||
| Q4 25 | 3.6% | 82.5% | ||
| Q3 25 | 2.9% | 56.6% | ||
| Q2 25 | 3.7% | 60.9% | ||
| Q1 25 | 2.7% | 68.1% | ||
| Q4 24 | 4.3% | 60.0% | ||
| Q3 24 | 4.6% | 43.2% | ||
| Q2 24 | 3.7% | 15.6% |
| Q1 26 | $0.18 | — | ||
| Q4 25 | $1.51 | $0.52 | ||
| Q3 25 | $1.02 | $0.35 | ||
| Q2 25 | $1.30 | $0.35 | ||
| Q1 25 | $0.81 | $0.35 | ||
| Q4 24 | $1.52 | $0.30 | ||
| Q3 24 | $1.19 | $0.21 | ||
| Q2 24 | $0.75 | $0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $41.8M | $198.0M |
| Total DebtLower is stronger | — | $894.2M |
| Stockholders' EquityBook value | $118.4M | $4.0B |
| Total Assets | $458.8M | $5.1B |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $41.8M | — | ||
| Q4 25 | $36.6M | $198.0M | ||
| Q3 25 | $49.8M | $712.5M | ||
| Q2 25 | $28.6M | $306.1M | ||
| Q1 25 | $32.5M | $26.5M | ||
| Q4 24 | $29.8M | $213.8M | ||
| Q3 24 | $22.1M | $377.1M | ||
| Q2 24 | $48.4M | $495.1M |
| Q1 26 | — | — | ||
| Q4 25 | — | $894.2M | ||
| Q3 25 | — | $893.8M | ||
| Q2 25 | — | $1.2B | ||
| Q1 25 | — | $822.1M | ||
| Q4 24 | — | $396.9M | ||
| Q3 24 | — | $396.7M | ||
| Q2 24 | — | $671.1M |
| Q1 26 | $118.4M | — | ||
| Q4 25 | $116.6M | $4.0B | ||
| Q3 25 | $109.3M | $4.0B | ||
| Q2 25 | $105.2M | $3.3B | ||
| Q1 25 | $95.6M | $2.9B | ||
| Q4 24 | $90.6M | $2.9B | ||
| Q3 24 | $87.7M | $2.4B | ||
| Q2 24 | $79.8M | $1.9B |
| Q1 26 | $458.8M | — | ||
| Q4 25 | $460.2M | $5.1B | ||
| Q3 25 | $376.1M | $5.1B | ||
| Q2 25 | $420.7M | $4.7B | ||
| Q1 25 | $370.1M | $3.9B | ||
| Q4 24 | $469.2M | $3.4B | ||
| Q3 24 | $371.9M | $2.9B | ||
| Q2 24 | $302.8M | $2.7B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.22× | ||
| Q2 25 | — | 0.35× | ||
| Q1 25 | — | 0.28× | ||
| Q4 24 | — | 0.14× | ||
| Q3 24 | — | 0.16× | ||
| Q2 24 | — | 0.35× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $394.0M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | 3.54× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $-11.9M | $394.0M | ||
| Q3 25 | $22.2M | $100.9M | ||
| Q2 25 | $-2.2M | $100.8M | ||
| Q1 25 | $8.5M | $71.4M | ||
| Q4 24 | $16.0M | $244.3M | ||
| Q3 24 | $-3.6M | $67.2M | ||
| Q2 24 | $7.3M | $53.0M |
| Q1 26 | — | — | ||
| Q4 25 | -1.70× | 3.54× | ||
| Q3 25 | 4.73× | 1.35× | ||
| Q2 25 | -0.37× | 1.47× | ||
| Q1 25 | 2.30× | 1.08× | ||
| Q4 24 | 2.29× | 4.68× | ||
| Q3 24 | -0.66× | 2.01× | ||
| Q2 24 | 2.13× | 4.92× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
